-

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224624

Enrollment

Registered

2019-04-02

Start date

2019-03-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : Oteseconazole Therapeutic category code : 629 Other chemotherapeutics Dosage and Administration for Investigational ma

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
efficacy	—

Countries

Europe, Japan, North America

Contacts

Public ContactjRCT IQVIA staffs

IQVIA Services Japan G.K.

Mycovia_CL011_JP_Registry@quintiles.com+81-3-6859-9500

Outcome results